So it's interesting to see that curve separate where we see patients coming off of GLP-1 therapy but staying good CPAP patients because they've realized, I may or may not be able to tolerate this drug or afford this drug, but I can't go another day without a good night sleep.
3-aminobenzamide (3-AB) is a competitive inhibitor of PARP enzymes, particularly PARP1 171,172
It hasnt been approved for use anywhere in the world, yet its already circulating through illicit online markets
FEBS Open Bio 14 , 13651377 (2024)
Connect with others on a similar journey Look for local or online support groups, including community wellness programs, peer groups, or virtual forums
The good news is that most individuals recover once their bodies stabilize